Last 286.80 GBp
Change Today -4.10 / -1.41%
Volume 687.0K
As of 8:19 AM 09/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John S. Patterson CBE, MBChB, FRCP, Fmed Sci

Former Executive Director and Member of Science Committee, AstraZeneca PLC
AgeTotal Calculated CompensationThis person is connected to 6 board members in 2 different organizations across 4 different industries.

See Board Relationships
66--

Background*

Dr. John S. Patterson, CBE, MBChB, FRCP, Fmed Sci, served as an Executive Vice President of Business Development, Product Strategy & Licensing of AstraZeneca PLC from 1999 to 2004. Dr. Patterson served as an Executive Director of Drug Development of Astrazeneca Plc from December 2005 to January 2009. He has extensive operational and development experience. He has a broad knowledge of overseas operations and a range of related skills and experience which will complement ...

Read Full Background

Corporate Headquarters*

Brook Road
Wimborne, Dorset BH21 2BJ

United Kingdom

Phone: 44 12 0288 2020
Fax: 44 12 0284 0523

Board Members Memberships*

Director
Member of Board of Directors
2001-N/A
Former Independent Non-Executive Director
2005-2009
Former Executive Director and Member of Science Committee
2005-2014
Former Independent Non-Executive Director, Chairman of Remuneration Committee and Member of Nomination Committee

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
COB:LN 286.80 GBp -4.10

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.3M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
kr15.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COBHAM PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.